|
Astellas Pharma to Shut Down North Carolina-Based Urology Research Facility
Astellas Pharma, a Japan-based pharmaceutical company, has announced its decision to shut down one of its subsidiaries, Urogenix, which is a research facility focusing on drug discovery in the field of urology.
Pharmaceutical Business Review |
Register Now
Archives